Supernus Pharmaceuticals
Price & Volume
Stats
See more52W Range | $25.53-$39.37 |
Market Cap | $2B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $651.9M |
Revenue Growth (YoY) | 14.2% |
Gross Profit (12 Mos) | $580M |
Diluted EPS | $1.09 |
News
See moreYahoo Finance • 2 months ago
Supernus Pharmaceuticals to Host Webcast to Review Open-Label Phase 2a Study of SPN-820 for the Treatment of Major Depressive Disorder
Yahoo Finance • 7 months ago
Supernus Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.002 (vs US$0.31 in 1Q 2023)
Yahoo Finance • 12 months ago
Supernus Pharmaceuticals (NASDAQ:SUPN) shareholders have earned a 8.7% CAGR over the last three years
Yahoo Finance • last year
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2023 Earnings Call Transcript
About
CEO | Mr. Jack A. Khattar M.B.A. |
CFO | Mr. Timothy C. Dec |
Address | 9715 Key West Avenue, Rockville, MD, United States, 20850 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 652 |
